A bill to help local educational agencies reduce chronic absenteeism and create safe learning environments in public elementary schools and secondary schools, and for other purposes.
Sponsor

Full profile: /officials/B001267
Source: Congress.gov · FEC
Cosponsors (0)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2026-06-23
Source: Congress.gov
Committee Activity
Currently in
- Senate Committee on Health, Education, Labor, and PensionsReferred To · 2026-06-23
Plain-English Summary
Plain-English summary pending. Introduced on 2026-06-23. Check back soon — summaries are generated as bills progress through Congress.
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- S4865A bill to prohibit discrimination against individuals with disabilities who need long-term services and supports, and for other purposes.Referred to Committee · 2026-06-23
- S4866A bill to amend the Farm Security and Rural Investment Act of 2002 to expand investment in farmers' markets and farmers' market nutrition programs to strengthen communities and improve access to healthy food, and for other purposes.Referred to Committee · 2026-06-23
- S4862A bill to direct the Secretary of Agriculture to consider certain acreage not planted due to a lack of irrigation water to be eligible for prevented planting payments, and for other purposes.Referred to Committee · 2026-06-23
- S4875A bill to amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infections, and for other purposes.Referred to Committee · 2026-06-23